Senior Director, Payer Accounts

Join Immatics and shape the future of cancer immunotherapy; one patient at a time!  

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. 

Why Join Us? 

• Innovative Environment: Help to pioneer advancements in cancer immunotherapy. 

• Collaborative Culture: Be part of a diverse team dedicated to your professional growth. 

• Global Impact: Contribute to therapies that make a lasting impact on patients globally. 

Role Overview:

The Senior Director, Payer Accounts will play a critical leadership role in shaping and executing our U.S. market access strategy with national and regional payers (commercial and government) in preparation for our first cell therapy launch. This is a high-impact, field-based position responsible for building relationships with key payer stakeholders, communicating product value and disease state unmet need, and ultimately securing favorable coverage and reimbursement pathways. This is a highly strategic and autonomous role that is ideal for an experienced national account professional who thrives in fast-paced environment and understands the complexity of launching innovative, high-value therapies.   

 
Reports to: Executive Director, Payer Accounts, Trade and Distribution 
Location: Remote 

Salary Range: $260,000 - $300,000 

Basic Qualifications: 

• Bachelor’s degree with 12+ years of pharmaceutical or biotech market access experience 

• 5+ years of national payer account management experience or similar role calling on payers (i.e., HEOR Field) 

• Cell or gene therapy experience

Preferred Qualifications:  

• MBA or other graduate degree  

• Proven track record of managing national commercial payer accounts, including pre-launch (PIE) and launch readiness for specialty or rare disease products 

• In-depth understanding of health economics, outcomes research, and the evolving reimbursement landscape for high-innovation drugs 

• Cell therapy experience in working with the payer community  

• Strategic thinker with strong analytical skills, capable of navigating complex, ambiguous payer environments with speed and precision